Pfizer, BioNTech lose UK appeal to Moderna in Covid-19 vaccine patent fight
The Appeals Court in London upheld an earlier UK court decision in the long-running battle between the global pharma firms.
It found that one of the European patents held by Moderna was invalid, but that a second one had been broken by Pfizer and its German partner BioNTech.
"The judge made no error of law or principle" in the ruling handed down in July 2024, the Appeal Court judges wrote Friday, dismissing the appeal brought by the two companies.
Pfizer quickly said it will appeal Friday's ruling to Britain's Supreme Court.
"Today's UK Court of Appeal's decision does not change our unwavering stance that this patent is invalid," Pfizer said in a statement. "This decision has no immediate impact on Pfizer and BioNTech."
Pfizer and BioNTech had argued that both the patents cited by Moderna were invalid, and neither had been infringed.
Friday's decision could have wide implications for other cases involving the huge pharma companies in the United States, Germany, Belgium, the Netherlands and Ireland.
Moderna said in a statement it was pleased with Friday's ruling and would "continue to pursue and enforce its patent rights globally to protect its innovative mRNA technology."
A UK court was told last year the firms had spent £19 million (US$25 million) fighting their legal battles.
In 2020, Pfizer and BioNTech's vaccine became the first ever mRNA vaccine approved for widespread use, and was swiftly deployed to combat the Covid pandemic.
Scientists believe mRNA vaccines, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against many diseases.
Traditional vaccines contain some form of the dead or inactivated target virus.
Since the virus need not be grown in the lab, mRNA vaccines can in theory be developed at scale more quickly than traditional vaccines.
In March, a German court in Duesseldorf also found Pfizer and BioNTech had violated a Moderna patent filed between 2010 to 2016 to make their vaccines.
It ordered they must provide estimates of how much they had profited from breaking the patent as well as provide "appropriate compensation."--AFP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
4 hours ago
- The Star
More than 10,000 European hotels seeking damages from Booking.com
The hotels cite a ruling by the European Court of Justice dated September 19, 2024 that essentially states that the best-price clause is illegal. — REUTERS/Dado Ruvic/Illustration/File Photo ROME: More than 10,000 European hotels are joining collective legal action against Amsterdam-based to seek compensation for losses caused by the online travel agency's use of so-called "best price" clauses. According to reports, the best price clauses could be in violation of antitrust law, but a court in Amsterdam must ultimately resolve the case. These clauses had prevented hotels from offering their rooms at a lower price outside the platform, such as on their own website. The aim is to prevent so-called "free-rider" bookings where customers find the hotel on and then go to the hotel's own website to make their booking. The hotels cite a ruling by the European Court of Justice dated September 19, 2024 that essentially states that the best-price clause is illegal. The court found that platforms like could operate without rules of this kind. This made little difference to travellers. had abolished the clauses in Europe following the European Union's Digital Markets Act of 2024. "European hoteliers have long suffered from unfair conditions and excessive costs. Now is the time to stand together and demand redress," Alexandros Vassilikos, president of the HOTREC hospitality sector association, said. "This joint initiative sends a clear message: abusive practices in the digital market will not be tolerated by the hospitality industry in Europe," he added. The aim of the collective action, known as a class action lawsuit, is to secure compensation for damages incurred between 2004 and 2024. The action, which is being supported by HOTREC and more than 30 national hotel associations, will be heard by a Dutch court and coordinated by the Hotel Claims Alliance. Despite the criticism, is essential for many hotels, as it allows them to reach a large customer base. According to a study conducted by HOTREC and a Swiss hoteliers' college, Booking Holdings held a market share of 71% across Europe in 2023, while the share of direct bookings has declined considerably over recent years. – dpa
New Straits Times
4 hours ago
- New Straits Times
Nissan begins talks with union to cut jobs at European regional office
TOKYO: Nissan Motor has begun negotiations with the union representing staff at its European regional office about changes that will include job losses, according to a company document and internal emails. The struggling Japanese automaker, which has embarked on a major restructuring, confirmed it has entered consultations with staff representatives at Nissan Automotive Europe, its regional office in Montigny-le-Bretonneux, France, which has around 560 staff. The office, which also oversees Nissan's operations for Africa, the Middle East, India and Oceania, is set to undergo major changes, according to a person with knowledge of the issue who declined to be identified. Management and the union agreed to discuss voluntary redundancies before any forced layoffs, the document seen by Reuters showed. Talks are expected to conclude by October 20, with full details to be shared with staff in November, the document and the emails said. "We are working diligently and respectfully with all parties to ensure that this process is conducted with care, transparency and in full compliance with legal requirements," Massimiliano Messina, Nissan's vice chairperson for the region, said in a July 31 email. Messina also said in the email that no decisions had yet been made. After taking the helm in April, CEO Ivan Espinosa announced a sweeping restructuring that includes cutting about 15 per cent of Nissan's workforce, slashing global production capacity by nearly 30 per cent to 2.5 million vehicles and the number of its manufacturing sites to 10 from 17. The automaker, which has seen weak sales in China and the U.S. compound pain brought on from an expansionist strategy, hopes to save 500 billion yen (US$3.4 billion) with the restructuring. In recent developments, Nissan said last week it would stop output at its Civac plant in Mexico by March next year. It also said it will end car production at its Oppama plant in Japan by March 2028 and at Nissan-Shatai's Shonan factory by March 2027. The automaker employs nearly 19,000 people across Europe, Africa, the Middle East, India and Oceania, with close to 60 per cent based in Europe, according to a diversity report published in October 2024.
New Straits Times
4 hours ago
- New Straits Times
BP makes its largest oil and gas discovery in 25 years offshore Brazil
BP has made its largest oil and gas discovery in 25 years offshore Brazil, it said on Monday, in a potential big boost for the British company following its strategic shift away from renewable energy to refocus on fossil fuels. BP is seeking to bolster oil and gas in its portfolio to regain investor confidence and revive underperforming shares. It said it planned to create a major new output hub at the Bumerangue discovery in Brazil, which a BP spokesperson said was probably the company's biggest since Shah Deniz in 1999, a gas and condensate field in the Azeri part of the Caspian Sea. Shah Deniz, with around 1 trillion cubic metres of gas and 2 billion barrels of condensate initially in place, produced 28 billion standard cubic metres of gas last year, according to BP. It gave no reserve estimate for the Brazilian block. "Brazil is an important country for BP, and our ambition is to explore the potential of establishing a material and advantaged production hub in the country," said Gordon Birrell, BP's production and operations chief. BP shares gained 1.3 per cent by 1107 GMT, outperforming a broader index of European energy companies which was up 0.1 per cent. This find may well see BP's upstream portfolio longevity extending well into the 2030s/40s, and it is this that has been the biggest issue and concern," Bernstein analyst Irene Himona said in a note. "Although we cannot extrapolate as it is too early, and each well and each reservoir is different, we believe the data ... provides support that the potential scale for this 100 per cent BP discovery could be a game changer." BP, which forecast its oil and gas production at 2.3 million to 2.5 million barrels of oil equivalent per day by 2030, said this was its tenth discovery this year, following findings in Trinidad, Egypt, Brazil and others. Production in 2024 was 2.4 million barrels of oil equivalent. BP expects production to be lower in 2025. BP had secured the Bumerangue block in the Santos basin amid pre-salt rocks in deep water offshore Brazil in December 2022 with what it said were "very good commercial terms". Early results indicate elevated levels of carbon dioxide in the Brazilian block, BP said, adding that further analysis would give more insight into its potential amid a bigger drilling programme in Brazil. Fellow London-listed rival Shell this year made a final investment decision for another project in the Santos Basin. BP is set to report its second-quarter results on Tuesday.
